Works about SCHIZOPHRENIA treatment


Results: 4603
    1
    2
    4

    Amisulpride induced mania.

    Published in:
    Indian Journal of Pharmacology, 2010, v. 42, n. 2, p. 112, doi. 10.4103/0253-7613.64496
    By:
    • Aggarwal, Ashish;
    • Jain, Manish;
    • Khandelwal, Ashish;
    • Jiloha, R. C.
    Publication type:
    Article
    5

    Negative effects of psychotherapies: A systematic review.

    Published in:
    Counselling & Psychotherapy Research, 2022, v. 22, n. 2, p. 267, doi. 10.1002/capr.12423
    By:
    • Paveltchuk, Fernanda;
    • Mourão, Sabrina Emely de Queiroz;
    • Keffer, Stella;
    • da Costa, Rafael Thomaz;
    • Nardi, Antonio Egídio;
    • de Carvalho, Marcele Regine
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13

    Esquizofrenia, VI.

    Published in:
    American Journal of Psychiatry - Edición Española, 2004, v. 7, n. 1, p. 23
    By:
    • Lieberman, Jeffrey A.;
    • Stroup, T. Scott
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20

    Predictive factors of overall functioning improvement in patients with chronic schizophrenia and schizoaffective disorder treated with paliperidone palmitate and aripiprazole monohydrate.

    Published in:
    Human Psychopharmacology: Clinical & Experimental, 2018, v. 33, n. 3, p. 1, doi. 10.1002/hup.2658
    By:
    • Girardi, Paolo;
    • Del Casale, Antonio;
    • Rapinesi, Chiara;
    • Kotzalidis, Georgios D.;
    • Splendori, Francesca;
    • Verzura, Claudio;
    • Trovini, Giada;
    • Sorice, Serena;
    • Carrus, Dario;
    • Mancinelli, Iginia;
    • Comparelli, Anna;
    • De Filippis, Sergio;
    • Francomano, Antonio;
    • Ballerini, Andrea;
    • Marcellusi, Andrea;
    • Mennini, Francesco S.;
    • Ducci, Giuseppe;
    • Sani, Gabriele;
    • Pompili, Maurizio;
    • Brugnoli, Roberto
    Publication type:
    Article
    21
    22
    23
    24
    25

    Association study between the neurexin-1 gene and tardive dyskinesia.

    Published in:
    Human Psychopharmacology: Clinical & Experimental, 2017, v. 32, n. 1, p. n/a, doi. 10.1002/hup.2568
    By:
    • Lanning, Rachel;
    • Lett, Tristram A.;
    • Tiwari, Arun K.;
    • Brandl, Eva J.;
    • Luca, Vincenzo;
    • Voineskos, Aristotle N.;
    • Potkin, Steven G.;
    • Lieberman, Jeffrey A.;
    • Meltzer, Herbert Y.;
    • Müller, Daniel J.;
    • Remington, Gary;
    • Kennedy, James L.;
    • Zai, Clement C.
    Publication type:
    Article
    26
    27

    Adjunctive antidepressant use in schizophrenia in China: A national survey (2002-2012).

    Published in:
    Human Psychopharmacology: Clinical & Experimental, 2017, v. 32, n. 1, p. n/a, doi. 10.1002/hup.2571
    By:
    • Li, Qian;
    • Su, Yun‐Ai;
    • Xiang, Yu‐Tao;
    • Shu, Liang;
    • Yu, Xin;
    • Ungvari, Gabor S.;
    • Ng, Chee H.;
    • Chiu, Helen F.K.;
    • Ning, Yu‐Ping;
    • Wang, Gao‐Hua;
    • Zhang, Ke‐Rang;
    • Li, Tao;
    • Sun, Li‐Zhong;
    • Shi, Jian‐Guo;
    • Chen, Xian‐Sheng;
    • Mei, Qi‐Yi;
    • Li, Ke‐Qing;
    • Si, Tian‐Mei
    Publication type:
    Article
    28
    29
    30

    The effects of pioglitazone adjuvant therapy on negative symptoms of patients with chronic schizophrenia: a double-blind and placebo-controlled trial.

    Published in:
    Human Psychopharmacology: Clinical & Experimental, 2016, v. 31, n. 2, p. 103, doi. 10.1002/hup.2517
    By:
    • Iranpour, Negar;
    • Zandifar, Atefeh;
    • Farokhnia, Mehdi;
    • Goguol, Amirhossein;
    • Yekehtaz, Habibeh;
    • Khodaie ‐ Ardakani, Mohammad ‐ Reza;
    • Salehi, Bahman;
    • Esalatmanesh, Sophia;
    • Zeionoddini, Atefeh;
    • Mohammadinejad, Payam;
    • Zeinoddini, Arefeh;
    • Akhondzadeh, Shahin
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50